Neuromuscular Blocks: Clinical Trials

1 trial for Neuromuscular Blocks, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Neuromuscular Blocks: new trials by email Literature Review of Neuromuscular Blocks trials Research Report on Neuromuscular Blocks

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
2 mg/kg sugammadex, 0.07 mg/kg neostigmine - Neuromuscular Blocks
Phase 3RecruitingThe Cleveland Clinic802024-06-012025-12-15

Interventions

Neostigmine (1)  ·  Sugammadex (1)

Sponsors

The Cleveland Clinic (1)

Countries

United States (1)

Top investigators

Ryu Komatsu, MD (1)